Error: Could not add to watchlist. X
+ Watchlist

Harel 4B Selected Biomed

IL30EQY:IT
2,114.96
ILs
9.74
0.46%
As of 12:59 AM EST 2/23/2017
Fund Type
Open-End Fund
52Wk Range
1,974.43 - 2,388.11
1 Yr Return
8.48%
YTD Return
-0.24%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
2,124.70
52Wk Range
1,974.43 - 2,388.11
1 Yr Return
6.50%
YTD Return
-0.24%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Israel
NAV (on 02/23/2017)
2,114.96
Total Assets (m ILS) (on 01/31/2017)
8.500
Inception Date
01/01/1993
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
2.51%
Expense Ratio
2.94%

Top Fund Holdings

Name Position Value % of Fund
17.00 k 766.70 k 9.60
31.00 k 730.36 k 9.14
120.00 k 693.96 k 8.69
31.00 k 659.37 k 8.25
16.00 k 640.80 k 8.02
30.00 k 625.50 k 7.83
200.00 k 536.00 k 6.71
390.00 419.68 k 5.25
90.00 k 392.58 k 4.91
22.00 k 375.76 k 4.70
Profile
Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.
Address
Ilanot Fund Management
Phone
-
Website
-